Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
Recruiting · NCT06910670 · Interventional (participants receive a specific treatment) · Lead sponsor: Washington University School of Medicine
View the official record on ClinicalTrials.gov →Interventions studied
Genetics Advisor Decision AidStandard developed materials
What this trial is about
The overall goal of the randomized control trial (RCT) will be to evaluate the efficacy of modifications to a web-based tool for patient decision-making regarding return of genomic results that will more closely focus on rare cancers. Participants will be given access to a web-based decision aid (or a standard control) that guides participants in making decisions about what type of genomic results they would like to receive from testing performed in the PE-CGS study (NCT06340646).
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Eligibility criteria (as published)
Eligibility Criteria:
* Enrolled in the WU-PE-CGS study (IRB#202106129); that eligibility entails:
* Diagnosis of cholangiocarcinoma
* Diagnosis of multiple myeloma, must be African American
* Diagnosis of colorectal cancer, must be African American and age 65 or older at time of diagnosis
* At least 18 years old.
* Able to understand an IRB-approved informed consent document and agree to participation
* Have access to a personal computer, tablet or mobile device
Where it is running
1 location listed across 1 US state.
- Washington University School of Medicine - St Louis, Missouri, United States